VOTIS Subdermal Imaging

VOTIS Subdermal Imaging Technologies, Ltd. provides clinical decision support for the diagnosis and monitoring of diabetic foot syndrome and related conditions, designed for safe repeated use over time and acute use during surgical procedures. The process is non-invasive and free of ionizing radiation, offering doctors objective, repeatable, and measurable data regardless of the treatment regimen. Subdermal imaging technology can help diabetic patients preserve their feet by enabling early screening of peripheral vascular disease and related complications. Early screening can provide new treatment options and help reduce amputation events. The company’s developed device is non-invasive, contact-free, radiation-free, and functionally aligns with the guidelines of the AHA, American Diabetes Association, and other leading medical organizations, which will reduce healthcare costs for hospitals, clinics, and insurance companies.